329 related articles for article (PubMed ID: 32249396)
1. Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission Model.
Gordon J; Darlington O; McEwan P; Lumley M; Taie A; Hicks M; Charbonneau C; Blake A; Hawkins N; Goldenberg S; Otter J; Wilcox M
Pharmacoeconomics; 2020 Aug; 38(8):857-869. PubMed ID: 32249396
[TBL] [Abstract][Full Text] [Related]
2. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use.
Shrestha P; Cooper BS; Coast J; Oppong R; Do Thi Thuy N; Phodha T; Celhay O; Guerin PJ; Wertheim H; Lubell Y
Antimicrob Resist Infect Control; 2018; 7():98. PubMed ID: 30116525
[TBL] [Abstract][Full Text] [Related]
3. Excess annual economic burdens from nosocomial infections caused by multi-drug resistant bacteria in Thailand.
Phodha T; Riewpaiboon A; Malathum K; Coyte PC
Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):305-312. PubMed ID: 30321493
[TBL] [Abstract][Full Text] [Related]
4. Using the best available data to estimate the cost of antimicrobial resistance: a systematic review.
Wozniak TM; Barnsbee L; Lee XJ; Pacella RE
Antimicrob Resist Infect Control; 2019; 8():26. PubMed ID: 30733860
[TBL] [Abstract][Full Text] [Related]
5. Quantifying the Economic and Clinical Value of Reducing Antimicrobial Resistance in Gram-negative Pathogens Causing Hospital-Acquired Infections in Australia.
Gordon JP; Al Taie A; Miller RL; Dennis JW; Blaskovich MAT; Iredell JR; Turnidge JD; Coombs GW; Grolman DC; Youssef J
Infect Dis Ther; 2023 Jul; 12(7):1875-1889. PubMed ID: 37341866
[TBL] [Abstract][Full Text] [Related]
6. Impact of vaccines on antimicrobial resistance.
Buchy P; Ascioglu S; Buisson Y; Datta S; Nissen M; Tambyah PA; Vong S
Int J Infect Dis; 2020 Jan; 90():188-196. PubMed ID: 31622674
[TBL] [Abstract][Full Text] [Related]
7. Population-level mathematical modeling of antimicrobial resistance: a systematic review.
Niewiadomska AM; Jayabalasingham B; Seidman JC; Willem L; Grenfell B; Spiro D; Viboud C
BMC Med; 2019 Apr; 17(1):81. PubMed ID: 31014341
[TBL] [Abstract][Full Text] [Related]
8. Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan.
Matsumoto T; Darlington O; Miller R; Gordon J; McEwan P; Ohashi T; Taie A; Yuasa A
J Health Econ Outcomes Res; 2021; 8(2):64-75. PubMed ID: 34703834
[No Abstract] [Full Text] [Related]
9. Genetic diversity and risk factors for the transmission of antimicrobial resistance across human, animals and environmental compartments in East Africa: a review.
Katale BZ; Misinzo G; Mshana SE; Chiyangi H; Campino S; Clark TG; Good L; Rweyemamu MM; Matee MI
Antimicrob Resist Infect Control; 2020 Aug; 9(1):127. PubMed ID: 32762743
[TBL] [Abstract][Full Text] [Related]
10. Estimating the Treatment and Prophylactic Economic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the USA: A Population Modelling Study.
Gordon J; Gheorghe M; Harrison C; Miller R; Dennis J; Steuten L; Goldenberg S; Gandra S; Al-Taie A
Pharmacoeconomics; 2024 Mar; 42(3):329-341. PubMed ID: 38001394
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic impact of bacterial resistance: an approach to infection control and antimicrobial stewardship solutions.
Calbo E; Boix-Palop L; Garau J
Curr Opin Infect Dis; 2020 Dec; 33(6):458-463. PubMed ID: 33074997
[TBL] [Abstract][Full Text] [Related]
12. Global geographic trends in antimicrobial resistance: the role of international travel.
Frost I; Van Boeckel TP; Pires J; Craig J; Laxminarayan R
J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31115466
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance: A global emerging threat to public health systems.
Ferri M; Ranucci E; Romagnoli P; Giaccone V
Crit Rev Food Sci Nutr; 2017 Sep; 57(13):2857-2876. PubMed ID: 26464037
[TBL] [Abstract][Full Text] [Related]
14. A protocol for a systematic literature review of economic evaluation studies of interventions to address antimicrobial resistance.
Ananthakrishnan A; Painter C; Teerawattananon Y
Syst Rev; 2021 Sep; 10(1):242. PubMed ID: 34488879
[TBL] [Abstract][Full Text] [Related]
15. Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.
Dhingra S; Rahman NAA; Peile E; Rahman M; Sartelli M; Hassali MA; Islam T; Islam S; Haque M
Front Public Health; 2020; 8():535668. PubMed ID: 33251170
[TBL] [Abstract][Full Text] [Related]
16. Impact of Antibiotic Resistance on Treatment of Pneumococcal Disease in Ethiopia: An Agent-Based Modeling Simulation.
Chen HH; Stringer A; Eguale T; Rao GG; Ozawa S
Am J Trop Med Hyg; 2019 Nov; 101(5):1042-1053. PubMed ID: 31516111
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic resistance as a major public health concern: epidemiology and economic impact.
Ciorba V; Odone A; Veronesi L; Pasquarella C; Signorelli C
Ann Ig; 2015; 27(3):562-79. PubMed ID: 26152543
[TBL] [Abstract][Full Text] [Related]
18. A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study.
Touat M; Opatowski M; Brun-Buisson C; Cosker K; Guillemot D; Salomon J; Tuppin P; de Lagasnerie G; Watier L
Appl Health Econ Health Policy; 2019 Jun; 17(3):381-389. PubMed ID: 30506456
[TBL] [Abstract][Full Text] [Related]
19. The role of vaccines in fighting antimicrobial resistance (AMR).
Jansen KU; Anderson AS
Hum Vaccin Immunother; 2018; 14(9):2142-2149. PubMed ID: 29787323
[TBL] [Abstract][Full Text] [Related]
20. An overview of the global antimicrobial resistance research and development hub and the current landscape.
Mattar C; Edwards S; Baraldi E; Hood J
Curr Opin Microbiol; 2020 Oct; 57():56-61. PubMed ID: 32777653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
